Patients should inform their procedural and anesthesia teams if they take GLP-1 or dual incretin therapy, including Ozempic, Wegovy, Rybelsus, Trulicity, Victoza, Saxenda, Mounjaro, or Zepbound
These procedures eliminate extra skin, tighten underlying tissues, and contour the body to new weight and proportions
When lifestyle changes are not enough, many people turn to medical support
You may be a candidate if you have: BMI 27 kg/m with obesity-related health problems BMI 30 kg/m Type 2 diabetes with overweight Fatty liver disease PCOS with obesity Sleep apnea High blood pressure Difficulty losing weight despite lifestyle changes A complete medical evaluation is essential before starting treatment
Moreover, a large number of clinical trials and early regulatory approvals accelerate the introduction of new formulations
The first GLP-1 drugs developed are self-administered via daily or weekly subcutaneous (under the skin) injections using a pre-filled pen